Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,219,331
-
Share change
-
-3,465,155
-
Total reported value
-
$6,169,000
-
Price per share
-
$0.67
-
Number of holders
-
26
-
Value change
-
-$2,226,049
-
Number of buys
-
9
-
Number of sells
-
13
Institutional Holders of AVIRAGEN THERAPEUTICS INC - COM (AVIR) as of Q2 2017
As of 30 Jun 2017,
AVIRAGEN THERAPEUTICS INC - COM (AVIR) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,219,331 shares.
The largest 10 holders included
Krensavage Asset Management, LLC, ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., GABELLI & Co INVESTMENT ADVISERS, INC., Virtu KCG Holdings LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and TOWERVIEW LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.